Literature DB >> 6648008

Objective regression of unexcised melanoma in-transit metastases after hyperthermic isolation perfusion of the limbs with melphalan.

F J Lejeune, T Deloof, P Ewalenko, J Fruhling, M Jabri, M Mathieu, J M Nogaret, A Verhest.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6648008     DOI： 10.1007/978-3-642-82025-0_45

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


× No keyword cloud information.
  7 in total

1.  Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.

Authors:  Amanda K Raymond; Georgia M Beasley; Gloria Broadwater; Christina K Augustine; James C Padussis; Ryan Turley; Bercedis Peterson; Hilliard Seigler; Scott K Pruitt; Douglas S Tyler
Journal:  J Am Coll Surg       Date:  2011-04-13       Impact factor: 6.113

2.  [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities].

Authors:  M Manner; H Sinn; H Bubeck; C Kettelhack; P Schlag
Journal:  Langenbecks Arch Chir       Date:  1990

Review 3.  Subcutaneous metastases from melanoma: a discussion of clinical experience.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Katarzyna Kozak
Journal:  Melanoma Manag       Date:  2014-09-05

Review 4.  Surgery for Metastatic Melanoma: an Evolving Concept.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-11-06       Impact factor: 5.075

5.  Isolated regional perfusion in malignant melanoma of the extremities.

Authors:  H Schraffordt Koops; J Oldhoff; J W Oosterhuis; H Beekhuis
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

6.  In transit metastases of malignant melanoma treated by high dose rTNF alpha in combination with interferon-gamma and melphalan in isolation perfusion.

Authors:  D Liénard; F J Lejeune; P Ewalenko
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

Review 7.  Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: credits, debits, and future perspectives.

Authors:  A M Eggermont; T L ten Hagen
Journal:  Curr Oncol Rep       Date:  2001-07       Impact factor: 5.075
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.